Financial Performance - Total revenues for the three months ended September 30, 2024, were 85.9million,a26.967.7 million in the same period of 2023[71]. - For the nine months ended September 30, 2024, total revenues were 244.2million,representinga26.2193.5 million in the same period of 2023[71]. - Revenues for the three months ended September 30, 2024, were 85.9million,anincreaseof18.2 million or 26.9% compared to 67.7millionin2023[98].−RevenuesfortheninemonthsendedSeptember30,2024,were244.2 million, an increase of 50.7millionor26.2193.5 million in 2023[98]. - SaaS subscription revenues accounted for 95.5% of total revenues for the three months ended September 30, 2024, compared to 95.7% in the same period of 2023[71]. - SaaS subscription services revenue for the nine months ended September 30, 2024, was 233,437,000,up27183,446,000 in 2023[80]. - Adjusted EBITDA for the three months ended September 30, 2024, was 8,318,000,comparedto826,000 in the same period of 2023[93]. - Adjusted EBITDA for the three and nine months ended September 30, 2024, was 8.3millionand16.7 million, respectively, compared to 0.8millionand(4.6) million for the same periods in 2023[94]. Expenses - The company incurred net losses of 9.4millionand33.2 million for the three and nine months ended September 30, 2024, respectively[71]. - Research and development expenses represented 28.1% of revenues for the three months ended September 30, 2024[77]. - Research and development expenses for the three months ended September 30, 2024, were 24,133,000,anincreasefrom21,755,000 in 2023[91]. - Sales and marketing expenses for the nine months ended September 30, 2024, totaled 45,213,000,upfrom36,694,000 in 2023[91]. - Sales and marketing expenses increased by 2.5millionor20.73.9 million or 21.1% for the three months ended September 30, 2024, mainly due to higher personnel-related and software costs[110]. - Cost of revenues for the three months ended September 30, 2024, was 35,289,000,upfrom31,153,000 in 2023[91]. - Cost of revenues increased by 4.1millionor13.3342.1 million as of September 30, 2024, up 67.1millionor24.4275.0 million in 2023[95]. - Registered users grew to 19.5 million as of September 30, 2024, an increase of 2.6 million or 15.4% from 16.9 million in 2023[96]. - Revenue per Registered User (RPU) increased to 17.54asofSeptember30,2024,up1.26 or 7.7% from 16.28in2023[97].CashFlowandFinancing−NetcashprovidedbyoperatingactivitiesfortheninemonthsendedSeptember30,2024,was12.5 million, compared to a net cash used of 12.2millionforthesameperiodin2023[121][122].−Netcashprovidedbyinvestingactivitieswas26.0 million for the nine months ended September 30, 2024, compared to a net cash used of 16.4millionforthesameperiodin2023[124][125].−Netcashprovidedbyfinancingactivitieswas1.5 million for the nine months ended September 30, 2024, compared to a net cash used of 4.8millionforthesameperiodin2023[126][127].−AsofSeptember30,2024,thecompanyhad101.0 million in cash and cash equivalents and marketable securities, with an accumulated deficit of 468.6million[118].−ThecompanyenteredintoaSecondAmendmenttoitsAmendedCreditAgreement,increasingtheRevolvingFacilitycommitmentby65.0 million to a total of 125.0million[128].−ThecompanyhasnooutstandingborrowingsrelatedtotheAmendedCreditAgreementasofSeptember30,2024[128].−TotalinterestexpensefortheninemonthsendedSeptember30,2024,was0.3 million, a decrease from $5.5 million for the same period in 2023[133]. - The company was in compliance with all covenants under the Amended Credit Agreement as of September 30, 2024[132]. Future Outlook - The company expects to continue increasing investments in implementation, client support teams, and technology infrastructure to support growth[83]. - The effective tax rate is impacted by a valuation allowance against deferred tax assets, primarily consisting of state income taxes and deferred taxes related to acquired goodwill[90]. - The company is expected to cease qualifying as an emerging growth company as of December 31, 2024, based on the market value of its common stock held by non-affiliates[141].